| Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes B Zinman, C Wanner, JM Lachin, D Fitchett, E Bluhmki, ... New England Journal of Medicine 373 (22), 2117-2128, 2015 | 5101 | 2015 |
| Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome G Marchesini, E Bugianesi, G Forlani, F Cerrelli, M Lenzi, R Manini, ... Hepatology 37 (4), 917-923, 2003 | 2912 | 2003 |
| Nonalcoholic fatty liver disease: a feature of the metabolic syndrome G Marchesini, M Brizi, G Bianchi, S Tomassetti, E Bugianesi, M Lenzi, ... Diabetes 50 (8), 1844-1850, 2001 | 2784 | 2001 |
| Association of nonalcoholic fatty liver disease with insulin resistance G Marchesini, M Brizi, AM Morselli-Labate, G Bianchi, E Bugianesi, ... The American journal of medicine 107 (5), 450-455, 1999 | 1847 | 1999 |
| The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD P Angulo, JM Hui, G Marchesini, E Bugianesi, J George, GC Farrell, ... Hepatology 45 (4), 846-854, 2007 | 1791 | 2007 |
| Empagliflozin and progression of kidney dsease in type 2 diabetes C Wanner, SE Inzucchi, JM Lachin, D Fitchett, M von Eynatten, ... New england journal of medicine 375 (4), 323-334, 2016 | 1679 | 2016 |
| Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma E Bugianesi, N Leone, E Vanni, G Marchesini, F Brunello, P Carucci, ... Gastroenterology 123 (1), 134-140, 2002 | 1644 | 2002 |
| Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study G Bedogni, L Miglioli, F Masutti, C Tiribelli, G Marchesini, S Bellentani Hepatology 42 (1), 44-52, 2005 | 1489 | 2005 |
| A position statement on NAFLD/NASH based on the EASL 2009 special conference V Ratziu, S Bellentani, H Cortez-Pinto, C Day, G Marchesini Journal of hepatology 53 (2), 372-384, 2010 | 1003 | 2010 |
| Metformin in non-alcoholic steatohepatitis G Marchesini, G Bianchi, S Tomassetti, M Zoli, N Melchionda The Lancet 358 (9285), 893-894, 2001 | 965 | 2001 |
| Clinical features and natural history of nonalcoholic steatosis syndromes Y Falck-Ytter, ZM Younossi, G Marchesini, AJ McCullough Seminars in liver disease 21 (01), 017-026, 2001 | 887 | 2001 |
| Insulin resistance: a metabolic pathway to chronic liver disease E Bugianesi, AJ McCullough, G Marchesini Hepatology 42 (5), 987-1000, 2005 | 854 | 2005 |
| A Randomized Controlled Trial of Metformin versus Vitamin E or Prescriptive Diet in Nonalcoholic Fatty Liver Disease E Bugianesi, E Gentilcore, R Manini, S Natale, E Vanni, N Villanova, ... The American journal of gastroenterology 100 (5), 1082, 2005 | 813 | 2005 |
| A randomized, controlled trial of 3.0 mg of liraglutide in weight management X Pi‑Sunyer, A Astrup, K Fujioka, F Greenway, A Halpern, M Krempf, ... New England Journal of Medicine 373 (1), 11-22, 2015 | 779 | 2015 |
| Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease N Villanova, S Moscatiello, S Ramilli, E Bugianesi, D Magalotti, E Vanni, ... Hepatology 42 (2), 473-480, 2005 | 661 | 2005 |
| Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes AL Fracanzani, L Valenti, E Bugianesi, M Andreoletti, A Colli, E Vanni, ... Hepatology 48 (3), 792-798, 2008 | 621 | 2008 |
| A survey of adverse events in 11241 patients with chronic viral hepatitis treated with alfa interferon G Fattovich, G Giustina, S Favarato, A Ruol, ... Journal of Hepatology 24 (1), 38-47, 1996 | 606 | 1996 |
| Nutritional supplementation with branched-chain amino acids in advanced cirrhosis: a double-blind, randomized trial G Marchesini, G Bianchi, M Merli, P Amodio, C Panella, C Loguercio, ... Gastroenterology 124 (7), 1792-1801, 2003 | 557 | 2003 |
| Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver E Bugianesi, P Manzini, S D'Antico, E Vanni, F Longo, N Leone, ... Hepatology 39 (1), 179-187, 2004 | 489 | 2004 |
| ESPEN guidelines for nutrition in liver disease and transplantation M Plauth, M Merli, J Kondrup, A Weimann, P Ferenci, MJ Muller, ... Clinical Nutrition 16 (2), 43-55, 1997 | 484 | 1997 |
Giampaolo BianchiUniversità di BolognaVerified email at unibo.it
